Katerzia is a Oral Suspension in the Human Prescription Drug category. It is labeled and distributed by Azurity Pharmaceuticals, Inc.. The primary component is Amlodipine Benzoate.
| Product ID | 52652-5001_2ddc59f1-dc68-420a-889b-245b54144430 |
| NDC | 52652-5001 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Katerzia |
| Generic Name | Amlodipine |
| Dosage Form | Suspension |
| Route of Administration | ORAL |
| Marketing Start Date | 2019-08-15 |
| Marketing Category | NDA / NDA |
| Application Number | NDA211340 |
| Labeler Name | Azurity Pharmaceuticals, Inc. |
| Substance Name | AMLODIPINE BENZOATE |
| Active Ingredient Strength | 1 mg/mL |
| Pharm Classes | Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2019-08-15 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA211340 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2019-08-15 |
| Ingredient | Strength |
|---|---|
| AMLODIPINE | 1 mg/mL |
| SPL SET ID: | df673a4d-acb8-444c-a472-c87ab8cbd366 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 52652-5001 | Katerzia | Amlodipine |
| 33342-015 | Amlodipine | Amlodipine |
| 33342-016 | Amlodipine | Amlodipine |
| 0615-6582 | Amlodipine Besylate | Amlodipine |
| 46287-035 | NORLIQVA | amlodipine |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() KATERZIA 88492580 not registered Live/Pending |
Argentum Holdings, LLC 2019-06-27 |